Literature DB >> 23884938

Nicotine-modulated subunit stoichiometry affects stability and trafficking of α3β4 nicotinic receptor.

Francesca Mazzo1, Francesco Pistillo, Giovanni Grazioso, Francesco Clementi, Nica Borgese, Cecilia Gotti, Sara Francesca Colombo.   

Abstract

Heteromeric nAChRs are pentameric cation channels, composed of combinations of two or three α and three or two β subunits, which play key physiological roles in the central and peripheral nervous systems. The prototypical agonist nicotine acts intracellularly to upregulate many nAChR subtypes, a phenomenon that is thought to contribute to the nicotine dependence of cigarette smokers. The α3β4 subtype has recently been genetically linked to nicotine dependence and lung cancer; however, the mode of action of nicotine on this receptor subtype has been incompletely investigated. Here, using transfected mammalian cells as model system, we characterized the response of the human α3β4 receptor subtype to nicotine and the mechanism of action of the drug. Nicotine, when present at 1 mm concentration, elicited a ∼5-fold increase of cell surface α3β4 and showed a more modest upregulatory effect also at concentrations as low as 10 μM. Upregulation was obtained if nicotine was present during, but not after, pentamer assembly and was caused by increased stability and trafficking of receptors assembled in the presence of the drug. Experimental determinations as well as computational studies of subunit stoichiometry showed that nicotine favors assembly of pentamers with (α3)2(β4)3 stoichiometry; these are less prone than (α3)3(β4)2 receptors to proteasomal degradation and, because of the presence in the β subunit of an endoplasmic reticulum export motif, more efficiently transported to the plasma membrane. Our findings uncover a novel mechanism of nicotine-induced α3β4 nAChR upregulation that may be relevant also for other nAChR subtypes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23884938      PMCID: PMC6618676          DOI: 10.1523/JNEUROSCI.2393-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  The nicotine metabolite, cotinine, alters the assembly and trafficking of a subset of nicotinic acetylcholine receptors.

Authors:  Ashley M Fox; Faruk H Moonschi; Christopher I Richards
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

Review 2.  Inside-out neuropharmacology of nicotinic drugs.

Authors:  Brandon J Henderson; Henry A Lester
Journal:  Neuropharmacology       Date:  2015-02-04       Impact factor: 5.250

3.  Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model: a computational and experimental study using epibatidine-related molecular probes.

Authors:  Clelia Dallanoce; Giovanni Grazioso; Diego Yuri Pomè; Miriam Sciaccaluga; Carlo Matera; Cecilia Gotti; Sergio Fucile; Marco De Amici
Journal:  J Comput Aided Mol Des       Date:  2013-11-26       Impact factor: 3.686

4.  Probing the Allosteric Role of the α5 Subunit of α3β4α5 Nicotinic Acetylcholine Receptors by Functionally Selective Modulators and Ligands.

Authors:  Caroline Ray; Erik J Soderblom; Yushi Bai; F Ivy Carroll; Marc G Caron; Larry S Barak
Journal:  ACS Chem Biol       Date:  2017-01-24       Impact factor: 5.100

Review 5.  Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update.

Authors:  Arianna Crespi; Sara Francesca Colombo; Cecilia Gotti
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

Review 6.  Looking below the surface of nicotinic acetylcholine receptors.

Authors:  Clare Stokes; Millet Treinin; Roger L Papke
Journal:  Trends Pharmacol Sci       Date:  2015-06-08       Impact factor: 14.819

7.  Disturbed neuronal ER-Golgi sorting of unassembled glycine receptors suggests altered subcellular processing is a cause of human hyperekplexia.

Authors:  Natascha Schaefer; Christoph J Kluck; Kerry L Price; Heike Meiselbach; Nadine Vornberger; Stephan Schwarzinger; Stephanie Hartmann; Georg Langlhofer; Solveig Schulz; Nadja Schlegel; Knut Brockmann; Bryan Lynch; Cord-Michael Becker; Sarah C R Lummis; Carmen Villmann
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

8.  Chronic Menthol Does Not Change Stoichiometry or Functional Plasma Membrane Levels of Mouse α3β4-Containing Nicotinic Acetylcholine Receptors.

Authors:  Selvan Bavan; Charlene H Kim; Brandon J Henderson; Henry A Lester
Journal:  Mol Pharmacol       Date:  2019-01-22       Impact factor: 4.436

9.  A positive signal prevents secretory membrane cargo from recycling between the Golgi and the ER.

Authors:  Matteo Fossati; Sara F Colombo; Nica Borgese
Journal:  EMBO J       Date:  2014-07-25       Impact factor: 11.598

Review 10.  Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.

Authors:  Ruthie E Wittenberg; Shannon L Wolfman; Mariella De Biasi; John A Dani
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.